Case Study: Preparing for the Challenges of Late Stage Trials

Mark Currie, President of R&D at Ironwood Pharmaceuticals, shares his amazing journey driving a product from establishing the foundation for the discovery of linaclotide by Ironwood scientists and leading every aspect of linaclotide's development and regulatory review. He shares his thought processes, pressure points, and lessons learned in leading the R&D team to get a product successfully to market. For more information on the Chief Medical Officer Summit and details for the 7th annual program taking place April 4-5, 2019 in Boston, please visit theconferenceforum.org